Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI)

Subclass of:

424 - Drug, bio-affecting and body treating compositions

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
424780170 Aftertreated polymer (e.g., grafting, blocking, etc.) 226
424780370 Monomer contains oxygen 106
424780310 Polymer from ethylenic monomers only 95
424780100 Ion exchange resin 49
424780090 Anti-fouling composition (e.g., paints, etc.) 28
424780360 Nitrogen heterocycle 22
Entries
DocumentTitleDate
20100086513Method for Effecting Antimicrobial Activity Using Polyamine Analogues - A method for using polyamine analogues containing bulky hydrophobic groups against antimicrobial agents is disclosed. The antimicrobial method works by the mechanical action of disrupting the protective outer member of a bacterial cell.04-08-2010
20100104528Contact Lens Solution With a Tertiary Amine Oxide - An aqueous contact lens solution comprising less than 100 ppm of a tertiary amine oxide of general formula04-29-2010
20100158850DENDRIMER BASED MODULAR PLATFORMS - The present invention relates to novel therapeutic and diagnostic dendrimer based modular platforms (e.g., drug delivery platforms). In particular, the dendrimer based modular platforms are configured such that two or more dendrimers (e.g., PAMAM dendrimers) are coupled together (e.g., via a cycloaddition reaction) wherein each of the coupled dendrimers is functionalized (e.g., functionalized for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy). In some embodiments, the present invention provides dendrimer based modular platforms having coupled dendrimers (e.g., two or more coupled dendrimers) wherein each dendrimer is conjugated to one or more functional groups (e.g., therapeutic agent, imaging agent, targeting agent, triggering agent) (e.g., for specific targeting and/or therapeutic use of the dendrimer based modular platform). In some embodiments, the functional groups are conjugated to the dendrimers via a linker and/or a triggering agent. In addition, the present invention is directed to methods of synthesizing dendrimer based modular platforms, compositions comprising the dendrimer based modular platforms, as well as systems and methods utilizing the dendrimer based modular platforms (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer) diagnosis and/or therapy, etc.)).06-24-2010
20110142786LENS CARE SOLUTIONS FUNCTIONALIZED ALKYLDIMONIUM HYDROXYPROPYL ALKYLGLUCOSIDES - A contact lens care solution that includes a functionalized hydroxypropyl alkylglucoside. The functionalized hydroxypropyl alkylglucoside is typically in the form a mixture of various alkylglycosides because: (1) the functional reagents can react with any one or more of the many hydroxyl groups on the glycoside; and (2) the glycosides are present as a mixture of glycosides with a degree of polymerization from 1 to about 4. The solution will also include a buffer system to maintain the pH of the composition from 7.2 to 8.5. In particular, the solution can be formulated to clean and disinfect contact lenses or the solution is formulated as a rewet eye drop for use with contact lenses.06-16-2011
20090136440Mixtures of phosphorus-containing compounds, a process for their preparation, and their use as flame retardants - The invention relates to mixtures of compounds of the formulae (I), (III), (IV), and/or (V),05-28-2009
20100178268BIOCIDIC PACKAGING FOR COSMETICS AND FOODSTUFFS - The present invention presents a biocidic packaging for cosmetics and/or foodstuffs, comprises at least one insoluble proton sink or source (PSS). The packaging is provided useful for killing living target cells (LTCs), or otherwise disrupting vital intracellular processes and/or intercellular interactions of said LTC upon contact. The PSS comprises, inter alia, (i) proton source or sink providing a buffering capacity; and (ii) means providing proton conductivity and/or electrical potential. The PSS is effectively disrupting the pH homeostasis and/or electrical balance within the confined volume of the LTC and/or disrupting vital intercellular interactions of the LTCs while efficiently preserving the pH of said LTCs' environment. The present invention also discloses a method for killing living target cells (LTCs), or otherwise disrupting vital intracellular processes and/or intercellular interactions of said LTC being in a packaging, especially cosmetic or foodstuffs' packaging.07-15-2010
20100135948Anti-Autoimmune Antibodies for Treatment of Pemphigus - This invention relates to compositions and methods for the use of anti-autoimmune reagents that specifically bind to anti-desmoglein antibodies, which are responsible for both pemphigus vulgaris and pemphigus foliaceus. In addition, the invention relates to methods and compositions for inhibiting the expression or function of a variable region of an anti-desmoglein (anti-Dsg) pathogenic autoantibody.06-03-2010
20090148395BIOMEDICAL FOAM ARTICLES - The present invention relates to biomedical foam articles for the wound sector which are formed by spraying a polymeric dispersion onto a wound. The polymeric dispersion being sprayed onto a wound surface forms a three-dimensional body which conforms to the spatial shape of the wound and which, as well as covering the wound surface, ensures a complete and accurately fitted packing of the wound in the depth dimension as well as the other dimensions. The biomedical foam articles of the present invention are particularly useful for treating chronic wounds.06-11-2009
20100034769COMPOSITIONS FOR TISSUE AUGMENTATION - Methods for making biomaterials for augmentation of soft and hard tissues, kits containing precursors for forming the biomaterials, and the resulting biomaterials are described herein. The biomaterials are formed from at least a first and a second precursor component. The first precursor component contains at least two nucleophilic groups, and the second precursor component contains at least two electrophilic groups. The nucleophilic and electrophilic groups of the first and second precursor components form covalent linkages with each other at physiological temperatures. The precursors are selected based on the desired properties of the biomaterial. In the preferred embodiment, the first precursor is a siloxane. Optionally, the biomaterials contain additives, such as thixotropic agents, radiopaque agents, or bioactive agents. In the preferred embodiment, the biomaterials are used to augment at least one vertebra of the spine (vertebroplasty).02-11-2010
20100086514Contact Lens Care Solutions with a Low Molecular Weight Oligomer - A contact lens care solution comprising: a cationic antimicrobial component having an average molecular weight (M04-08-2010
20080317699Chemically modified dendrimers - Dendrimers comprising N-acyl urea terminal moieties are described herein. The dendrimers can be used, for example, in the treatment of arthritis.12-25-2008
20090104142COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS - The present invention relates to compositions comprising Tr1 cells directed to a multiple sclerosis associated antigen and methods for treating multiple sclerosis.04-23-2009
20090123411Molecular Fingerprints With Enhanced Identifying Capability, Method for Preparing Same and Use Thereof - The invention concerns a method for preparing a molecular fingerprint comprising sites for identifying at least one target molecule, said fingerprint being obtained from at least one master molecule of polymeric type, called master polymer. The invention is characterized in that said master polymer is different from the target molecule(s), and is capable of being eliminated by degradation and/or washing, and that at least 5% in number of monomer units constituting the master polymer are involved in the formation of the sites for identifying the target molecule(s).05-14-2009
20090252699MEDICAL DEVICES WITH AN ANTIMICROBIAL POLYURETHANE COATING - The present invention relates to a medical device comprising a coating which is obtainable starting from a solution comprising a nonionic polyurethaneurea and silver.10-08-2009
20090053165Method for Treating Damaged Hair - The present invention relates to a method for treating damaged hair comprising the steps of: a) contacting the hair with a shampoo composition, the shampoo comprising: from about 5% to about 50% of an anionic surfactant; from about 0.025% to about 5% by weight of a synthetic cationic polymer having a cationic charge density from about 2 meq/gm to about 7 meq/gm, wherein the synthetic cationic polymer forms lyotropic liquid crystals upon combination with the anionic surfactant; and water; and b) rinsing the composition from the hair, where, following the treatment, silicone deposition efficiency (DE) on the hair is greater than 1.02-26-2009
20090098082substiuted organopolysiloxanes and use thereof - The invention relates to new compounds of Formula 04-16-2009
20100266524Composition Comprising Silicone Oil or Oils Structured With Compolymers Carrying Greater Than 70% Long Chain Alkyl Group - The present invention discloses silicone oils which are structured with a copolymer comprising a large percentage of alkane groups. Using high percentage pendant alkane helps provide silicone with ideal gel properties (G′>G″, particularly >1000 cP, more preferably 2000-30,000 cP) and viscosity, after fracture, of 10 to 1000 cP, preferably 30-500 cP MW of polymer and exact chain length are selected to ensure that, when forming gel upon cooling after mixing polymer and silicone, the polymer viscosity will not be so high upon crystal formation that gel cannot form, yet also will not be so low that polymer will phase separate.10-21-2010
20080267901Biocompatible Polymer Networks - Functionalized prepolymers and biocompatible polymer networks are disclosed, especially biodegradable polymer networks obtainable by polymerization of the functionalized prepolymers by for example ultraviolet (UV), redox, and/or heat radical polymerization. Functionalized prepolymers (macromers) are obtainable by reaction of a prepolymer comprising at least one alcohol, amine, and/or sulfhydril group, with an unsaturated mono-esterified dicarbonic acid, especially fumaric acid mono-ethyl ester.10-30-2008
20100055065AGENT FOR INHIBITING PRODUCTION OF HEPATITIS C VIRUS AND ITS USE - This invention provides an agent for inhibiting production of hepatitis C virus with notable anti-HCV activity and without side-effects. The agent comprises a proanthocyanidin polymer composition illustrated in the following the general formula (1),03-04-2010
20110212046ALTERNATING RING-OPENING METATHESIS POLYMERIZATION - The invention relates to the field of polymers and olefin polymerization, and more specifically olefin metathesis polymerization. The invention provides regioregular alternating polymers and methods of synthesizing such polymers.09-01-2011
20100196305SULFONE POLYMER COMPOSITIONS - Sulfone-containing copolymers and copolymer networks and compositions including sulfone-containing copolymers and copolymer networks may be used to bind target ions, such as phosphorous-containing compounds in the gastrointestinal tract of animals. In some cases, sulfone-containing copolymers and copolymer networks may be derived from a multi-amine monomer and a multifunctional sulfonyl-containing monomer comprising two or more amine-reactive groups.08-05-2010
20100068167Low Salt Forms of Polyallylamine - Disclosed is a pharmaceutical composition comprising a stable polyallylamine hydrochloride polymer in which between about 4% to about 12% by weight of the polymer is a chloride anion and a pharmaceutically acceptable carrier or diluent.03-18-2010
20100028291MICROBICIDAL AND ANTISEPTIC GEL COMPOSITION - A microbicidal and antiseptic composition, which comprises the following (a), (b) and (c): 02-04-2010
20100322890Pathogen eradication composition - Disinfecting compositions comprising the synergistic combinations of polymerized quaternary ammonium compounds and super spreading agents, integrated with substrates that need protection from pathogens. The aqueous based polymers require minimal use of organic solvents in their preparation, contain no volatile organic compounds, and are mild to the user. The composition may be integrated, by coating or by pre-form blending, with either a hydrophilic or lipophilic substrate needing microbial protection properties. Once integrated, the composition properties of electrostatic attraction and microbial destruction are non-consuming and non-leaching, giving the substrate sustained efficacy against viruses, fungi, bacteria, and spores that contact it.12-23-2010
20130011361PYRAZOLE DERIVATIVES WHICH MODULATE STEAROYL-COA DESATURASE - The present invention provides heterocyclic derivatives of formula (I) that modulate the activity of stearoyl-CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl-CoA desaturase and pharmaceutical compositions comprising such derivatives are also encompassed.01-10-2013
20120003175THERAPEUTIC USES OF MASTIC GUM FRACTIONS - The invention relates to pharmaceutical compositions and formulations comprising polymeric myrcene. More particularly, the invention relates to compositions comprising an isolated fraction of polymeric myrcene in a hydrophobic carrier and formulations which maintain the biological activity of the active polymer.01-05-2012
20110091408METHODS OF USING FLUOROALKYL PHOSPHATE COMPOSITIONS - Fluoroalkyl phosphates containing a tertiary carbon and a nonfluorinated chain are useful as surfactants and additives. The f can be used to alter a surface property of a medium and to provide resistance to blocking, open time extension, or oil repellency to a substrate.04-21-2011
20100092419MAGNETIC FLUIDS AND THEIR USE - Disclosed are magnetic fluids containing ionic liquids and containing no stabilisation agents or containing selected stabilisation agents. These magnetic fluids can be used in different fields of industry, for example as an ink, as a damping fluid, as a sealing fluid, in imaging applications, in sink flotation techniques, in biomedical applications, as a reaction medium to perform chemical reactions, as a reversible seal for occluding blood vessels in living organisms in medical therapy or as a transportation means and/or delivery means for chemical substances at a selected location within a chemical or biological system.04-15-2010
20100172861Anionic Polymers as Toxin Binders and Antibacterial Agents - The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.07-08-2010
20100272670BIODEGRADABLE POLYANHYDRIDES WITH NATURAL BIOACTIVE MOLECULES - The invention provides polymers that include a biologically active molecule and methods for their use.10-28-2010
20080317698Personal Care Compositions Containing At Least Two Cationic Polymers and an Anionic Surfactant - A personal cleansing composition comprising: 12-25-2008
20080299068Skin Preparation For External Use - The present invention provides an external composition for skin that has excellent effects in improving elasticity and alleviating wrinkles while moisturizing the skin, has good spreadability on the skin, and has no stickiness. The external composition for skin of the present invention is characterized by comprising: (A) an acrylic polymer comprising the following monomers (a1), (a2), and (a3) as constituent monomers: (a1) acrylic acid or methacrylic acid; (a2) an alkyl acrylate or alkyl methacrylate; and (a3) an ester between acrylic acid or methacrylic acid and polyoxyethylene alkyl ether; and (B) a cross-linked polyamino acid or its salt. In the external composition for skin of the present invention, it is preferable that (A) is 0.01 to 10.0 weight % as a polymer, and (B) is 0.0001 to 5.0 weight % as a polymer.12-04-2008
20100233115Multilayer Fibrous Polymer Scaffolds, Methods of Production and Methods of Use - Fibrous polymer scaffolds and methods of manufacture are provided. The scaffolds can be formed of multiple layers and the extent and direction of alignment of each layer can be controlled. Efficient fabrication systems and methods for producing such scaffolds include apparatuses and processes are also provided. Kits including the fibrous polymer scaffolds and methods for implanting such scaffolds are also provided.09-16-2010

Patent applications in class SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI)

Patent applications in all subclasses SOLID SYNTHETIC ORGANIC POLYMER AS DESIGNATED ORGANIC ACTIVE INGREDIENT (DOAI)